Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 91.3B | 115.8B | 96.4B | 114.0B |
Cost of revenue | 74.2B | 93.0B | 78.5B | 94.2B |
Gross profit | 17.1B | 22.8B | 17.9B | 19.8B |
Operating expense | ||||
Research & development | — | 128.8M | 108.1M | 155.9M |
Selling general and admin | 13.4B | 13.9B | 9.0B | 9.8B |
Other operating expenses | — | 362.9M | 180.9M | 127.9M |
Operating income | 17.1B | 3.2B | 4.2B | 5.3B |
Non operating interest income | ||||
Income | — | 900.7M | 1.0B | 694.4M |
Expense | — | 62.6M | 41.6M | 53.9M |
Other income expense | — | — | — | — |
Pretax income | 4.9B | 3.8B | 4.4B | 6.1B |
Tax provision | 1.0B | 1.4B | 939.4M | 1.4B |
Net income | 3.9B | 2.4B | 3.4B | 4.8B |
Basic EPS | 176.4 | — | 151 | 212 |
Diluted EPS | 176.4 | — | 151 | 212 |
Basic average shares | — | — | 21.5M | 21.5M |
Diluted average shares | — | — | 21.5M | 21.5M |
EBITDA | 17.1B | 6.9B | 7.0B | 8.2B |
Net income from continuing op. | — | 2.4B | 3.4B | 4.8B |
Minority interests | -87.9M | 62.3M | -178.2M | -222.8M |
Preferred stock dividends | — | — | — | — |